Analystreport

Pacira Pharmaceuticals Inc (NASDAQ: PCRX) had its "hold" rating re-affirmed by analysts at Mizuho. They now have a $43.00 price target on the stock.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com